Announcements
- ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2024
- ResMed to Report Third Quarter Fiscal 2024 Earnings on April 25, 2024
- ResMed's 2024 Global Sleep Survey Uncovers a World in Sleep Crisis
- Introducing the AirFit F40: Experience Unprecedented Freedom with the Comfort and Optimized Seal Performance of ResMed’s Smallest Full-Face CPAP Mask
- ResMed’s New AirCurve™ 11 Bilevel Devices Enable Healthcare Providers to Make Informed Decisions about Care, Deliver Personalized Support, and Drive Positive Therapy Outcomes for Patients with Sleep Apnea
- ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2024
- ResMed to Report Second Quarter Fiscal 2024 Earnings on January 24, 2024
- ResMed Announces Participation in the 42nd Annual J.P. Morgan Healthcare Conference
- ResMed Notifies Customers About Updated Instructions and Labeling for Masks with Magnets Due to Potential Interference with Certain Medical Devices
- ResMed Secures Significant Victory in Patent Fight Against New York University
More ▼
Key statistics
On Tuesday, RESMED INC DRN (R1MD34:SAO) closed at 276.08, -1.40% below its 52-week high of 280.00, set on Oct 02, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 276.36 |
---|---|
High | 276.36 |
Low | 275.80 |
Bid | 276.92 |
Offer | 278.04 |
Previous close | 278.16 |
Average volume | 93.33 |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Annual div (ADY) | 1.87 BRL |
---|---|
Annual div yield (ADY) | 0.68% |
Div ex-date | Feb 07 2024 |
Div pay-date | Mar 20 2024 |
Next div ex-date | May 08 2024 |
Next div pay-date | Jun 19 2024 |
Data delayed at least 15 minutes, as of Apr 30 2024 20:54 BST.
More ▼